Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention

Author(s): B. Wang, H. Zhou, Y. Luo, R. Tang, S. Zheng

Journal Name: Current Medicinal Chemistry

Volume 21 , Issue 22 , 2014

Become EABM
Become Reviewer
Call for Editor


Metastasis is responsible for most deaths of cancer burdens. Given that metastatic cancer cells are generally very low in quantity but high in multiplicity, and able to migrate to diverse organs, the diagnosis and intervention of metastatic cancers face varieties of challenges. For example, the biomarker for early diagnosis, and detection of circulating tumor cells by way of epithelial cell adhesion molecule, are complicated by the epithelial-mesenchymal-transition (EMT). Enhanced permeation and retention have been widely explored but with limitations, especially for microscale metastatic tumors. Furthermore, drug-resistance and side-effects of chemotherapy remain problematic for diverse cancers. Interfaces of cells play essential roles in many physiological activities including signal transduction and immunological recognition, which can be exploited for medical application of interfacial materials; indeed, given unique chemical and physical interfacial properties, numerous micro/nano particles and interfacial materials exhibit great potentials for diagnosis and intervention of metastatic cancers. Here we highlight current research, opportunities and challenges for application potentials of biological interfacial engineering in diagnosis and intervention of metastatic cancers.

Keywords: Biological interfacial engineering, cancer, cancer diagnosis and intervention, metastasis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 28 May, 2014
Page: [2510 - 2521]
Pages: 12
DOI: 10.2174/0929867321666131213102724
Price: $65

Article Metrics

PDF: 24